Market cap
₹6 Cr
Revenue (TTM)
₹160 Cr
P/E Ratio
--
P/B Ratio
--
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
2.1 %
-
ROCE
11.6 %
-
Industry P/E
42.09
-
EV/EBITDA
12
-
Debt to Equity
0.8
-
Book Value
₹--
-
EPS
₹-0.8
-
Face value
1
-
Shares outstanding
244,459,983
9 Years Aggregate
CFO
₹-14.70 Cr
EBITDA
₹230.48 Cr
Net Profit
₹93.58 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ameya Laboratories
| -4.0 | 20.0 | -11.1 | -11.1 | -49.6 | -48.9 | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
BSE Healthcare#
| 18.1 | 1.0 | 9.6 | 17.6 | 22.5 | 14.1 | 12.2 |
|
Company
|
2014
|
|---|---|
|
Ameya Laboratories
| -3.8 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ameya Laboratories
|
0.2 | 5.9 | 160.4 | -19.8 | 2.9 | -12.4 | -- | -- |
| 3,174.3 | 25,979.8 | 1,461.8 | 387.4 | 34.5 | 25.2 | 67.3 | 15.1 | |
| 843.9 | 16,595.8 | 7,784.0 | 688.5 | 10.6 | 14 | 23.9 | 2.8 | |
| 460.0 | 17,589.9 | 2,141.5 | 58.5 | 5.8 | 3.3 | 165.6 | 4.6 | |
| 837.2 | 20,755.5 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,527.9 | 17,502.0 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 213.2 | 28,384.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,822.2 | 30,127.6 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104.5 | 22.4 | |
| 402.1 | 16,213.4 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.4 | 3.4 | |
| 1,850.6 | 30,074.9 | 3,564.0 | 414.0 | 15.3 | 8.4 | 73.5 | 6.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Ameya Laboratories
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1996
-
Chairman
--
-
Managing Director
K Hari Babu
-
Headquarters
Hyderabad, Andhra Pradesh
-
Website
Looking for more details about Ameya Laboratories Ltd.’s IPO? Explore our IPO Details page.
FAQs for Ameya Laboratories
What is the current share price of Ameya Laboratories Ltd Today?
The share price of Ameya Laboratories Ltd is ₹0.24 (BSE) as of 16-Mar-2015 IST. Ameya Laboratories Ltd has given a return of -49.56% in the last 3 years.
What is the current PB & PE ratio of Ameya Laboratories Ltd?
Since, TTM earnings of Ameya Laboratories Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2012 |
12.44 |
0.26 |
2011 |
5.74 |
0.48 |
2010 |
7.52 |
1.03 |
2009 |
0.97 |
2.27 |
2008 |
0.00 |
0.00 |
What is the 52 Week High and Low of Ameya Laboratories Ltd?
The 52-week high and low of Ameya Laboratories Ltd are Rs -- and Rs -- as of 02-Sep-2026.
What is the market cap of Ameya Laboratories Ltd?
Ameya Laboratories Ltd has a market capitalisation of ₹ 6 Cr as on 16-Mar-2015. As per SEBI classification, it is a company.
Should I invest in Ameya Laboratories Ltd?
Before investing in Ameya Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.